- Promote the creation of a new model case by providing support for spin-out ventures from the establishment stage in order to contribute to the development of early stage seeds from domestic pharmaceutical companies
- Aim to promote open innovation by mobilizing resources and technological research in the pharmaceutical industry
- Contribute towards solving societal issues by providing innovative pharmaceutical products for intractable diseases with high unmet medical needs
Our Portfolio
Curadim Pharma Co., Ltd.
| Outline | R&D of pharmaceutical products |
|---|---|
| Website | |
| Industry | Health/medicine |
| Commercialization stage | Early stage |
Provided Support
| Authorized Investment | 1 billion yen (maximum)／1.2 billion yen (maximum) |
|---|---|
| Announcement Date | August 4, 2016／June 4, 2018 |
| Investment Structure |